The use of ex vivo human skin tissue for genotoxicity testing

Toxicology and Applied Pharmacology

Volumn 261, Issue 2, 2012, Pages 154-163

  Reus, Astrid A ^a   Usta, Mustafa ^a   Krul, Cyrille A M ^a  

^a TNO   (Netherlands)

Author keywords

Comet assay; Ex vivo human skin; Genotoxicity testing

Indexed keywords

SOLVENT;

ARTICLE; COMET ASSAY; DNA DAMAGE; EX VIVO STUDY; FEASIBILITY STUDY; GENOTOXICITY; GOVERNMENT REGULATION; HUMAN; HUMAN TISSUE; METABOLISM; PRACTICE GUIDELINE; REPRODUCIBILITY; SKIN CARCINOGENESIS; SKIN CULTURE; TOXICITY TESTING;

ADOLESCENT; ADULT; AGED; COMET ASSAY; FEMALE; HUMANS; MIDDLE AGED; MUTAGENICITY TESTS; MUTAGENS; REPRODUCIBILITY OF RESULTS; SKIN;

ANIMALIA;

EID: 84861008405     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.03.019     Document Type: Article

References (52)

1. 2003/15/EC Directive 2003 of the European Parliament and of the Council of 27 February 2003, amending Council Directive 76/78/EEC on the approximation of the laws of the Member States relating to cosmetic products. Off. J. Eur. Union 2003, 46:26-35.
2. Aardema M.J., Barnett B.C., Khambatta Z., Reisinger K., Ouedraogo-Arras G., Faquet B., Ginestet A.C., Mun G.C., Dahl E.L., Hewitt N.J., Corvi R., Curren R.D. International prevalidation studies of the EpiDerm™ human reconstructed skin micronucleus (RSMN) assay: transferability and reproducibility. Mutat. Res. 2010, 701:123-131.
3. Andersen A. Final amended report on the safety assessment of oxyquinoline and oxyquinoline sulfate as used in cosmetics. Int. J. Toxicol. 2006, 25(Suppl. 1):1-9.
4. Asakura S., Sawada S., Sugihara T., Daimon H., Sagami F. Quinoline-induced chromosome aberrations and sister chromatid exchanges in rat liver. Environ. Mol. Mutagen. 1997, 30:459-467.
5. Ashby J., Mohammed R., Lefevre P.A., Bandara L. Quinoline: unscheduled DNA synthesis and mitogenesis data from the rat liver in vivo. Environ. Mol. Mutagen. 1989, 14:221-228.
6. Bernard F.X., Barrault C., Deguercy A., De Wever B., Rosdy M. Development of a highly sensitive in vitro phototoxicity assay using the SkinEthic™ reconstructed human epidermis. Cell Biol. Toxicol. 2000, 16:391-400.
7. BUA GDCh-Advisory Committee on Existing Chemicals of Environmental Relevance (BUA): p-chloroaniline Accessed on 28 October 2011. http://www.hirzel.de/bua-report/PDF/Summary_Report153.pdf.
8. Cal K. Skin penetration of terpenes from essential oils and topical vehicles. Planta Med. 2006, 72:311-316.
9. Capon F., Cambie-Vanderschelden M.P., Salmon-Her V., Birembaut P., Kalis B., Maquart F.X. A comparative study of cryogenic lesions in organ-cultured human skin and in reconstituted human skin equivalent. Cryobiology 1998, 36:174-183.
10. Curren R.D., Mun G.C., Gibson D.P., Aardema M.J. Development of a method for assessing micronucleus induction in a 3D human skin model (EpiDerm™). Mutat. Res. 2006, 607:192-204.
11. Dahl E.L., Curren R., Barnett B.C., Khambatta Z., Reisinger K., Ouedraogo G., Faquet B., Ginestet A.C., Mun G., Hewitt N.J., Carr G., Pfuhler S., Aardema M.J. The reconstructed skin micronucleus assay (RSMN) in EpiDerm™: detailed protocol and harmonized scoring atlas. Mutat. Res. 2011, 720:42-52.
12. De Boeck M., Lison D., Kirsch-Volders M. Evaluation of the in vitro direct and indirect genotoxic effects of cobalt compounds using the alkaline comet assay. Influence of interdonor and interexperimental variability. Carcinogenesis 1998, 19:2021-2029.
13. EC 1907/2006 Regulation (EC) No 1907/2006 of the European Parliament and the Council of 18 December 2006, concerning the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), establishing a European Chemical Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/03 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EC, 93/67/EC, 93/105/EC and 2000/21/EC. Off. J. Eur. Union 2006, 49:1-849.
14. ECHA Guidance on information requirement and chemical safety assessment adopted May 2008. URL:, Accessed on 27 October 2011. http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_r7a_en.pdf.
15. Flamand N., Marrot L., Belaidi J.P., Bourouf L., Dourille E., Feltes M., Meunier J.R. Development of genotoxicity test procedures with EpiSkin®, a reconstructed human skin model: towards new tools for in vitro risk assessment of dermally applied compounds?. Mutat. Res. 2006, 606:39-51.
16. Gold L.S. The carcinogenicity potency project Last updated 3 October 2007. Accessed on 28 October 2011. http://potency.berkeley.edu/chempages/p-CHLOROANILINE.html.
17. Hamoud M.A., Ong T., Petersen M., Nath J. Effects of quinoline and 8-hydroxyquinoline on mouse bone marrow erythrocytes as measured by the micronucleus assay. Teratog. Carcinog. Mutagen. 1989, 9:111-118.
18. Hu T., Kaluzhny Y., Mun G.C., Barnett B., Karetsky V., Wilt N., Klausner M., Curre R.D., Aardema M.J. Intralaboratory and interlaboratory evaluation of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay. Mutat. Res. 2009, 673:100-108.
19. Hu T., Khambatta Z.S., Hayden P.J., Bolmarcich J., Binder R.L., Robinson M.K., Carr G.J., Tiesman J.P., Jarrold B.B., Osborne R., Reichling T.D., Nemeth S.T., Aardema M.J. Xenobiotic metabolism gene expression in the EpiDerm in vitro 3D human epidermis model compared to human skin. Toxicol. In Vitro 2010, 24:1450-1463.
20. Hughes M.F., Fisher H.L., Birnbaum L.S., Hall L.L. Effect of age on the in vitro percutaneous absorption of phenols in mice. Toxicol. In Vitro 1994, 8:221-227.
21. Kandárova H., Hayden P., Klausner M., Kubilus J., Kearney P., Sheasgreen J. In vitro skin irritation testing: improving the sensitivity of the EpiDerm skin irritation test protocol. Altern. Lab. Anim. 2009, 37:671-689.
22. Kidd D.A., Johnson M., Clements J. Development of an in vitro corrosion/irritation prediction assay using the EpiDerm skin model. Toxicol. In Vitro 2007, 21:1292-1297.
23. Kirkland D.J., Aardema M., Banduhn N., Carmichael P., Fautz R., Meunier J.R., Pfuhler S. In vitro approaches to develop weight of evidence (WoE) and mode of action (MoA) discussions with positive in vitro genotoxicity results. Mutagenesis 2007, 2:161-175.
24. Kirkland D., Pfuhler S., Tweats D., Aardema M., Corvi R., Darroudi F., Elhajouji A., Glatt H., Hastwell P., Hayashi M., Kasper P., Kirchner S., Lynch A., Marzin D., Maurici D., Meunier J.R., Müller L., Nohynek G., Parry J., Parry E., Thybaud V., Tice R., Van Benthem J., Vanparys P., White P. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM workshop. Mutat. Res. 2007, 628:31-55.
25. Kirkland D., Kasper P., Müller L., Corvi R., Speit G. Recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests: a follow-up to an ECVAM workshop. Mutat. Res. 2008, 653:99-108.
26. Lelièvre D., Justine P., Christiaens F., Bonaventure N., Coutet J., Marrot L., Cotovio J. The episkin phototoxicity assay (EPA): development of an in vitro tiered strategy using 17 reference chemicals to predict phototoxic potency. Toxicol. In Vitro 2007, 21:977-995.
27. Lovell D.P., Thomas G., Dubow R. Issues related to the experimental design and subsequent statistical analysis of in vivo and in vitro comet studies. Teratog Carcinog Mutagen 1999, 19:109-119.
28. Luu-The V., Duche D., Ferraris C., Meunier J.R., Leclaire J., Labrie F. Expression profiles of phases 1 and 2 metabolizing enzymes in human skin and the reconstructed skin models Episkin™ and full thickness model from Episkin™. J. Steroid Biochem. Mol. Biol. 2009, 116:178-186.
29. McFee A.F. Genotoxic potency of three quinoline compounds evaluated in vivo in mouse marrow cells. Environ. Mol. Mutagen. 1989, 13:325-331.
30. Miller M.A., Bhatt V., Kasting G.B. Dose and airflow dependence of benzyl alcohol disposition on skin. J. Pharm. Sci. 2006, 95:281-291.
31. Mun G.C., Aardema M.J., Hu T., Barnett B., Kaluzhny Y., Klausner M., Karetsky V., Dahl E.L., Curren R.D. Further development of the EpiDerm™ 3D reconstructed human skin micronucleus (RSMN) assay. Mutat. Res. 2009, 673:92-99.
32. Netzlaff F., Lehr C.M., Wertz P.W., Schaefer U.F. The human epidermis models EpiSkin®, SkinEthic® and EpiDerm®: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. Eur. J. Pharm. Biopharm. 2005, 60:167-178.
33. Nishikawa T., Haresaku M., Adachi K., Masuda M., Hayashi M. Study of a rat skin in vivo micronucleus test: data generated by mitomycin C and methyl methane sulfonate. Mutat. Res. 1999, 444:159-166.
34. NTP Comparative toxicity studies of o-, m-, and p-chloroanilines (CAS Nos. 95-51-2; 108-42-9; and 106-47-8) administered by gavage to F344/N rats and B6C3F1 mice. Toxic. Rep. Ser. 1998, 43:1-F20.
35. OECD 431 OECD guideline for the testing of chemicals: draft proposal for an update of test guideline 431: in vitro skin corrosion: reconstructed human epidermis (RhE) test method Adopted 13 April 2004. URL, Accessed 27 October 2011. http://www.oecd.org/dataoecd/63/6/43302385.pdf.
36. OECD 439 OECD guideline for the testing of chemicals: in vitro skin irritation: reconstructed human epidermis test method Adopted 22 July 2010. URL, Accessed 27 October 2011. http://iccvam.niehs.nih.gov/SuppDocs/FedDocs/OECD/OECD-TG439.pdf.
37. Portes P., Pygmalion J., Popovic E., Cottin M., Mariani M. Use of human reconstituted epidermis Episkin® for assessment of weak phototoxic potential of chemical compounds. Photodermatol. Photoimmunol. Photomed. 2002, 18:96-102.
38. Pungartnik C., Picada J., Brendel M., Henriques J.A.P. Further phenotypic characterization of pso mutants of Saccharomyces cerevisiae with respect to DNA repair and response to oxidative stress. Genet. Mol. Res. 2002, 1:79-89.
39. Reus A.A., Van Meeuwen R.N.C., De Vogel N., Maas W.J.M., Krul C.A.M. Development and characterisation of an in vitro photomicronucleus test using ex vivo human skin tissue. Mutagenesis 2011, 26:261-268.
40. Reus, A.A., Stelloo, E., Usta, M., Van den Wijngaard, M.J.M., Krul, C.A.M., in preparation. The use of ex vivo human skin tissue for photosafety testing.
41. Sasaki Y.F., Fujikawa K., Ishida K., Kawamura N., Nishikawa Y., Ohta S., Satoh M., Madarame H., Ueno S., Susa N., Matsusaka N., Tsuda S. The alkaline single cell gel electrophoresis assay with mouse multiple organs: results with 30 aromatic amines evaluated by the IARC and U.S. NTP. Mutat. Res. 1999, 440:1-18.
42. SCCS/1416/11 The SCCS notes of guidance for the testing of cosmetic ingredients and their safety evaluation. 7th revision adopted on 14 December 2010. URL, Accessed on 27 October 2011. http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_s_004.pdf.
43. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
44. Smith C.C., Adkins D.J., Martin E.A., O'Donovan M.R. Recommendations for design of the rat comet assay. Mutagenesis 2008, 23:233-240.
45. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.C., Sasaki Y.F. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 2000, 35:206-221.
46. Tornier C., Amsellem C., Fraissinette Ade B., Alépée N. Assessment of the optimized SkinEthic Reconstructed Human Epidermis (RHE) 42 bis skin irritation protocol over 39 test substances. Toxicol. In Vitro 2010, 24:245-256.
47. Van de Sandt J.J.M., Rutten A.A.J.J.L., Koëter H.B.W.M. Cutaneous toxicity testing in organ culture: neutral red uptake and reduction of tetrazolium salt (MTT). Toxicol. In Vitro 1993, 7:81-86.
48. Van de Sandt J.J.M., Bos T.A., Rutten A.A.J.J.L. Epidermal cell proliferation and terminal differentiation in skin organ culture after topical exposure to sodium dodecyl sulphate. In Vitro Cell. Dev. Biol. Anim. 1995, 31:761-766.
49. Wahlberg J.E., Boman A. 2-Chloroethanol-percutaneous toxicity of a solvent. Dermatologica 1978, 156:299-302.
50. Wirén K., Frithiof H., Sjöqvist C., Lodén M. Enhancement of bioavailability by lowering of fat content in topical formulations. Br. J. Dermatol. 2009, 160:552-556.
51. Yengi L.G., Xiang Q., Pan J., Scatina J., Kao J., Ball S.E., Fruncillo R., Ferron G., Wolf R.C. Quantitation of cytochrome P450 mRNA levels in human skin. Anal. Biochem. 2003, 316:103-110.
52. You B.Y., Wang Y.H., Kuo M.L. Role of reactive oxygen species in cupric 8-quinolinoxide-induced genotoxic effect. Mutat. Res. 2001, 491:45-56.